Trial Profile
Study of sorafenib and radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2018 Status changed from recruiting to discontinued.
- 20 Jun 2012 New trial record